Dermata Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.2% | -78.2% | -68.0% |
| FY2022 | -159.6% | -159.6% | -138.4% |
| FY2023 | -122.7% | -122.7% | -97.7% |
| FY2024 | -787.1% | -787.1% | -347.7% |
| FY2025 | -121.5% | -121.5% | -96.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -78.2% | -78.2% | -68.0% |
| FY2022 | -159.6% | -159.6% | -138.4% |
| FY2023 | -122.7% | -122.7% | -97.7% |
| FY2024 | -787.1% | -787.1% | -347.7% |
| FY2025 | -121.5% | -121.5% | -96.1% |